Dilemma of membrane biocompatibility and reuse

Artificial Organs

Volumn 20, Issue 6, 1996, Pages 426-432

  Klinkmann, H ^a   Grassmann, A ^b   Vienken, J ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b Akzo Nobel GmbH Germany   (Germany)

Author keywords

biocompatibility; dialysis; membranes; reprocessing; reuse

Indexed keywords

DIALYSIS; DIALYSIS MEMBRANES;

COMPLEMENT ACTIVATIONS; CYTOKINES; INNER SURFACES; LEUCOPENIA; MULTIPLE USE; PERFORMANCE; REPROCESSING; REUSE;

BIOCOMPATIBILITY;

BIOCOMPATIBILITY; BLEEDING; CONFERENCE PAPER; HEMODIALYSIS; HEMOFILTRATION; HUMAN; IMMUNITY; MEMBRANE FILTER; MORTALITY; PRIORITY JOURNAL; PROTEIN DEPLETION; RECYCLING; RISK ASSESSMENT;

EID: 0029982385     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04527.x     Document Type: Conference Paper

References (57)

1. Bregman H, Daugirdas JT, Ing TS. Complications during hemodialysis In: Daugirdas JT, Ing TS, eds Handbook of dialysis. Boston: Little Brown, 1988;II9:113-7.
2. Dolovich J, Marshall CP, Smith EKM, Shimizu A, Pearson FC, Sugona MA, Lee W. Allergy to ethylene oxide in chronic hemodialysis patients. Artif Organs 1984;8:334-7.
3. Charoenpanich R, Pollak VE, Kant KS, Robson MD, Cathey M. Effect of first and subsequent use of hemodialyzers on patient well-being: the rise and fall of a syndrome associated with new dialyzer use. Artif Organs 1987;11: 123-7.
4. Deane N, Wineman R. Multiple use of hemodialyzers. In: Maher J, ed. Replacement of renal function by dialysis. Boston: Kluwer Academic Publishers, 1983;18:400-16.
5. Hakim RM, Briellatt J, Lazarus JM, Port FK. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984;311:878-81.
6. Chenoweth DE. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications. Artif Organs 1984;8:281-7.
7. Daugirdas JT, Potempa LD, Dinh N, Gandhi VC, Ivanovich PT, Ing TS. Plate, coil and hollow-fiber cuprammonium cellulose dialyzers: discrepancy between incidence of anaphylactic reactions and degree of complement activation. Artif Organs 1987;11:140-3.
8. Johnson RJ. Complement activation during extracorporeal therapy: biochemistry, cell biology and clinical relevance. Nephrol Dial Transplant 1994;9:36-45.
9. Hakim RM, Fearon DT, Lazarus JM. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984;26:194-200.
10. Hoerl WH, Feinstein EI, Wanner C, Frischmuth N, Goesele A, Massry SG. Plasma levels of main granulocyte components during hemodialysis: comparison of new and reused dialyzers. Am J Nephrol 1990;10:53-7.
11. Stroncek DF, Keshaviah P, Craddock PR, Hammerschmidt D. Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis. J Lab Clin Med 1984;104: 304-11.
12. Dumler F, Zasuwa G, Levin NW. Effect of dialyzer reprocessing methods on complement activation and hemodialyzers-related symptoms. Artif Organs 1987;11:128-31.
13. Gagnon RF, Kaye M. Hemodialysis neutropenia and dialyzer reuse: role of the cleansing agent. Uremia Invest 1984;8:17-23.
14. Gagnon RF, Kaye M. Effect of cleansing agent on the biocompatibility of reused dialyzers. In: Nose Y, Kjellstrand C, Ivanovich P, eds. Progress in artificial organs 1985. Cleveland: ISAO Press, 1986:965-9.
15. Kuwahara T, Markert M, Wauters J-P. Biocompatibility aspects of dialyzer reprocessing: a comparison of 3 re-use methods and 3 membranes. Clin Nephrol 1989;32:139-43.
16. Hoenich NA, Johnston SRD, Buckley P, Harden J, Ward MK, Kerr DNS. Haemodialyser reuse: impact on function and biocompatibility. Int J Artif Organs 1983;6:261-6.
17. Levett DL, Woffindin C, Bird AG, Hoenich NA, Ward MK, Kerr DNS. Complement activation in haemodialysis: a comparison of new and re-used dialysers. Int J Artif Organs 1986;9:97-104.
18. Shusterman NH, Feldman HI, Wasserstein A, Strom BL. Reprocessing of hemodialyzers: a critical appraisal. Am J Kidney Dis 1989;14:81-91.
19. Heierli C, Markert M, Lambert PH, Kuwahara T, Wauters JP. On the mechanism of haemodialysis-induced neutropenia: a study with five new and reused membranes. Nephol Dial Transplant 1988;3:773-83.
20. Lemke HD. Synthesis of intracellular IL-1β and protein oxidation with cellulose acetate (CA) dialyzers reused with peracetic acid in vitro. (Abstract) J Am Soc Nephrol 1994; 5:519.
21. Tokars JI, Alter MJ, Favero MS, Moyer LA, Miller E, Bland LA. National surveillance of dialysis associated diseases in the United States, 1992. ASAIO J 1994;40:1020-31.
22. Pegues DA, Beck-Sague CM, Woollen SW, Greenspan B, Burns SM, Bland LA, Arduino MJ, Favero MS, Mackow RC, Jarvis WR. Anaphylaktoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int 1992;42:1232-7.
23. Vienken J, Diamontoglou M, Hahn C, Kamosewitz H, Paul D. Considerations on developmental aspects of biocompat-ible membranes. Artif Organs 1995:19:398-40.
24. Matsuda T. Biological responses at non-physiological interfaces and molecular design of biocompatible surfaces. Nephrol Dial Transplant 1989;4:60-6.
25. Lemke HD, Fink E. Generation of bradykinin in human plasma using AN69 and PAn 17DX membranes in the presence of an ACE inhibitor in vitro. Nephol Dial Transplant 1992;7:727-8.
26. Vanholder R, Noens L, De Smet R, Ringoir S. Development of anti-N-like antibodies during formaldehyde reuse in spite of adequate predialysis rinsing. Am J Kidney Dis 1988;11: 477-80.
27. Vanholder R, Ringoir S. Influence of reuse and of reuse sterilants on the first-use syndrome. Int Soc Artif Organs 1987;11:137-9.
28. Fassbinder W, Koch KM. A specific immunohaemolytic anaemia induced by formaldehyde sterilization of dialyzers. Contrib Nephrol 1983;36:51-67.
29. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of dialysis-associated diseases in the United States, 1991. ASAIO J 1993;39:966-75.
30. Beck-Sague CM, Jarvis WR, Bland LA, Arduino MJ, Aguero SM, Verosic G. Outbreak of gram-negative bacteremia and pyrogenic reactions in a hemodialysis center. Am J Nephrol 1990;10:397-403.
31. Feldman H, Kobrin S. Dialyzer reuse. In: Nissenson A, Fine R, Gentile D, eds. Clinical Dialysis, Norwalk: Appleton and Lange, 1995;268-280.
32. Miller GB. Update: acute allergic reactions associated with reprocessed hemodialyzers-United States, 1989-1990. Dialysis Transplant 1991;20:692-4.
33. Bland L, Alter M, Favero M, Carson L, Cusick L. Hemodialyzer reuse: practices in the United States and implication for infection control. ASAIO Trans 1985;31:556-9.
34. Boland G, Reingold AL, Carson LA, Silcox VA, Woodley CL, Hayes PS, Hightower AW, McFarland L, Brown JW, Petersen NJ, Favero MS, Good RC, Broome CV. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis 1985;152: 1013-9.
35. Vanholder R, Vanhaecke E, Ringoir S. Waterborne Pseudomonas septicemia. ASAIO Trans 1990;36:215-6.
36. Vanholder R, Vanhaecke E, Ringoir S. Pseudomonas septicemia due to deficient disinfectant mixing during reuse. Int J Artif Organs 1992;15:19-24.
37. Lowry PW, Beck-Sague CM, Bland LA, Aguero SM, Arduino MJ, Minuth AN, Murray RA, Swenson JM, Jarvis WR. Mycobacterium chelonae infection among patients receiving high-flux dialysis in a hemodialysis clinic in California. J Infect Dis 1990;161:85-90.
38. Lufft V, Mahiart A, Shaldon S, Koch K, Schindler R. Retention of cytokine-inducing substances inside high-flux dialyzers. Blood Purif. 1996;14:26-34.
39. Rudnick JR, Arduino MJ, Bland LA, Cusick L, McAllister SK, Ahuero SM, Jarvis WR. An outbreak of pryogenic reactions in chronic hemodialyzer patients associated with hemodialyzer reuse. Artif Organs 1995;19:289-94.
40. Harding GB, Klein E, Pass T, Wright R, Million C. Endotoxin and bacterial contamination of dialysis center water and dialysate; a cross sectional survey. Int J Artif Organs 1990;13:39-43.
41. Bambauer R, Schauer M, Jung WK, Daum V, Vienken J. Contamination of dialysis water and dialysate, a survey of 30 centers. ASAIO J 1994;40:1012-6.
42. Pinto dos Santos J, Loureiro A, Schmid CS, Ruthazer R, Pereira BJG. Dialysis room and reuse strategies that affect the incidence of hepatitis C (HVC) infection in HD units. J Am Soc Nephrol 1995;6:557.
43. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-82.
44. Ratore V, Depner TA, Shearer GC, Kaysen GA. Hypoalbuminemia results from reduced albumin synthesis (AlbSyn) determined primarily by non-nutritional factors in hemodialysis patients (Abstract). J Am Soc Nephrol 1994;5:502.
45. Kaplan AA, Halley SE, Lapkin RA, Graeber CW. Dialysate protein losses with bleach processed polysulphone dialyzers. Pre-print Kidney Int 1995:47.
46. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994;46: 830-7.
47. Krautzig S, Mahiout A, Koch KM, Lemke HD. Re-use with oxidizing agents leads to a loss of polyvinylpyrolidone from polysulfone membranes (Abstract). Blood Purif 1994;12:176.
48. Brunner FP, Selwood NH. Results of renal replacement therapy in Europe, 1980 to 1987. Am J Kidney Dis 1990;25: 384-96.
49. Eggers PW. Mortality rates among dialysis patients in Medicare's end-stage renal disease program. Am J Kidney Dis 1990;25:414-21.
50. Odaka M. Mortality in chronic dialysis patients in Japan. Am J Kidney Dis 1990;25:375-83.
51. Shaldon S. Influence of different dialysis strategies on patients survival in Europe. Japan and USA: 4th Berliner Dialysis Seminar, 1991:1-3.
52. Shaldon S, Koch KM. Survival and adequacy in long-term hemodialysis. Nephron 1991;59:353-7.
53. Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment (Abstract). JAMA 1991;265:871.
54. Zager P, Campbell M, Huni C, Brown R. Effect of dialyzer reprocessing on standardized mortality ratios within a large not-for-profit chain (Abstract). J Am Soc Nephrol 1994;5: 485.
55. Held PJ, Wolfe RA, Gaylin DS, Port FK, Levin NW, Turenne MN. Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis 1994;23: 692-708.
56. Ministere des Affaires Sociales, de la Sante et de la Ville, Direction des Hopitaux, Bureau EM 1. Circulaire DGS/SQ 3, DGS/PH 2-DH/EM 1 No. 51 du 29.12.94 relative à lútilisation des dispositifs médicaux stériles à usage unique dans les établissements de santé publics et privés. 1994 per text
57. British Medical Devices Agency (MDA), London. The reuse of medical devices supplied for single use only. MDA DB 9501, January 1995.